
18 August 2026 · 9 min read
BioPhotonix Advances PBM for Dry AMD and Dry Eye Through Collaboration and Research
Dry age-related macular degeneration is common, sight-threatening, and still without a widely used treatment for most people in its earlier dry form. That gap is what BioPhotonix is working on.
Read the article


